menu
    • menu

    Company profile for Graviti Pharmaceuticals

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Graviti Pharmaceuticals is a research-focused formulation firm established in Hyderabad, India to produce complex generics of the highest quality. Our efforts are specially focused on modified-release, bio and stability sensitive molecules, as well as novel drug delivery platforms. We consider superior manufacturing to be truly critical for success. We strive to meet and exceed regulatory standards to deliver products that ...
    Graviti Pharmaceuticals is a research-focused formulation firm established in Hyderabad, India to produce complex generics of the highest quality. Our efforts are specially focused on modified-release, bio and stability sensitive molecules, as well as novel drug delivery platforms. We consider superior manufacturing to be truly critical for success. We strive to meet and exceed regulatory standards to deliver products that are consistently of higher quality. We build lasting partnerships on a foundation of reliability, integrity, transparency and responsiveness.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Graviti Pharmaceuticalsindia-flag Flag
    Country
    Country
    India
    Address
    Address
    Plot Number 64, Nagarjuna Hills, Panjagutta, Hyderabad – 500 084, Telangana
    Telephone
    Telephone
    040 6815 5555
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.gravitipharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    SCOPE Summit

    SCOPE Summit

    Not Confirmed

    envelop Contact Supplier

    SCOPE Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enforcement Report - Week of January 28, 2026
    Enforcement Report - Week of January 28, 2026

    28 Jan 2026

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-28-2026-48857.pdf

    FDA
    28 Jan 2026
    Share Share
    Enforcement Report - Week of October 29, 2025
    Enforcement Report - Week of October 29, 2025

    29 Oct 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-29-2025-82388.pdf

    FDA
    29 Oct 2025
    Share Share
    Graviti Pharma`s Generics Tamsulosin HCl Receives Approval in US
    Graviti Pharma`s Generics Tamsulosin HCl Receives Approval in US

    01 May 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219767

    FDA
    01 May 2025
    Share Share
    Graviti Pharma`s Generics Trazodone HCl Receives Approval in US
    Graviti Pharma`s Generics Trazodone HCl Receives Approval in US

    27 Aug 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217740

    FDA
    27 Aug 2024
    Share Share
    Graviti Pharma`s Generic Famotidine Receives Approval in the U.S.
    Graviti Pharma`s Generic Famotidine Receives Approval in the U.S.

    14 Mar 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218461

    FDA
    14 Mar 2024
    Share Share
    Graviti's Generic Baclofen Receives Approval in the U.S.
    Graviti's Generic Baclofen Receives Approval in the U.S.

    10 Jan 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217788

    FDA
    10 Jan 2024
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Graviti Pharmaceuticals and get a quotation

    Graviti Pharmaceuticals is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find a price of Pantoprazole Sodium bulk with DMF offered by Graviti Pharmaceuticals

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search